| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibiotic therapy for osteoarticular infections in 2023: Proposals from the Pediatric Infectious Pathology Group (GPIP)
|
Lorrot, Mathie
|
|
|
|
8S |
p.
|
artikel
|
| 2 |
Antibiotic treatment of neuro-meningeal infections
|
Gillet, Yves
|
|
|
|
8S |
p.
|
artikel
|
| 3 |
Anti-infective treatment of gastro-intestinal tract infections in children
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 4 |
Antimicrobial treatment of ENT infections
|
Cohen, R.
|
|
|
|
8S |
p.
|
artikel
|
| 5 |
Antimicrobial treatment of infrequent bacterial species
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 6 |
Antimicrobial treatment of lower respiratory tract infections in children
|
Madhi, Fouad
|
|
|
|
8S |
p.
|
artikel
|
| 7 |
Antimicrobial treatment of skin and soft tissue infections
|
Gillet, Yves
|
|
|
|
8S |
p.
|
artikel
|
| 8 |
Antimicrobial treatment of urinary tract infections in children
|
Madhi, Fouad
|
|
|
|
8S |
p.
|
artikel
|
| 9 |
Attitudes of French adults toward COVID-19 vaccination
|
Ward, J.K.
|
|
|
|
8S |
p. S19-S20
|
artikel
|
| 10 |
Attitudes of healthcare professionals toward the COVID-19 vaccination campaign in France
|
Mueller, J.E.
|
|
|
|
8S |
p. S21-S22
|
artikel
|
| 11 |
Bon usage des antibiotiques, infections à bactéries multirésistantes et nouvelles molécules
|
Mascitti, H.
|
|
|
|
8S |
p. 51/8S1-51/8S5
|
artikel
|
| 12 |
Contents
|
|
|
|
|
8S |
p.
|
artikel
|
| 13 |
Definitions and implications of the pharmacokinetic-pharmacodynamic parameters of antibiotics in pediatric clinical practice
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 14 |
Editorial board
|
|
|
|
|
8S |
p. i
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
|
8S |
p. ii
|
artikel
|
| 16 |
Editorial board
|
|
|
|
|
8S |
p.
|
artikel
|
| 17 |
Grippe et Covid-19
|
Jaffal, K.
|
|
|
|
8S |
p. 51/8S6-51/8S11
|
artikel
|
| 18 |
Heterologous prime boost COVID 19 vaccination
|
Launay, O.
|
|
|
|
8S |
p. S7-S8
|
artikel
|
| 19 |
Infections ostéoarticulaires
|
Mascitti, H.
|
|
|
|
8S |
p. 51/8S12-51/8S16
|
artikel
|
| 20 |
Neonatal bacterial infections: Diagnosis, bacterial epidemiology and antibiotic treatment
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 21 |
Nouveautés sur la pneumocystose et le CMV chez l’immunodeprimé (hors VIH)
|
Mascitti, H.
|
|
|
|
8S |
p. 51/8S17-51/8S19
|
artikel
|
| 22 |
Nouveaux critères de l’EUCAST
|
Jaffal, K.
|
|
|
|
8S |
p. 51/8S20-51/8S25
|
artikel
|
| 23 |
Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France
|
Crommelynck, S.
|
|
|
|
8S |
p. S16-S18
|
artikel
|
| 24 |
SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy
|
Lina, B.
|
|
|
|
8S |
p. S2-S3
|
artikel
|
| 25 |
The principles of curative antibiotic treatments
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 26 |
The SARS-CoV-2 vaccines: Retrospective and perspectives
|
Epaulard, Olivier
|
|
|
|
8S |
p. S1
|
artikel
|
| 27 |
Title Page
|
|
|
|
|
8S |
p. i
|
artikel
|
| 28 |
Treatment of Resistant Gram-negative bacilli in children
|
Cohen, Robert
|
|
|
|
8S |
p.
|
artikel
|
| 29 |
Vaccinating children: The pros and cons
|
Cohen, R.
|
|
|
|
8S |
p. S9-S11
|
artikel
|
| 30 |
What are the prospects for durable immune control?
|
Lelievre, J.D.
|
|
|
|
8S |
p. S4-S6
|
artikel
|
| 31 |
What progress has been made in treatment of immunocompromised COVID-19 patients?
|
Ader, F.
|
|
|
|
8S |
p. S12-S15
|
artikel
|
Tijdschrift beschrijving